243 related articles for article (PubMed ID: 3886219)
21. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
22. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
23. Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria.
Srichaikul T; Puwasatien P; Karnjanajetanee J; Bokisch VA; Pawasatien P
Lancet; 1975 Apr; 1(7910):770-2. PubMed ID: 48001
[TBL] [Abstract][Full Text] [Related]
24. Correlation of Plasmodium falciparum gametocytemia with complement component titers in rural Nigerian school children.
Ade-Serrano MA; Ejezie GC; Kassim OO
J Clin Microbiol; 1981 Jan; 13(1):195-8. PubMed ID: 7007423
[TBL] [Abstract][Full Text] [Related]
25. Pre- & post-treatment levels of serum complement levels (C3 & C4) in children with malaria.
Kidwai T; Ahmad SH; Ahmad S; Hussain Z; Malik A; Khan TA
Indian J Med Res; 1985 Nov; 82():408-11. PubMed ID: 3912321
[No Abstract] [Full Text] [Related]
26. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
27. Complement components in kidney allograft recipients: relationship to cytomegalovirus infection.
Chatterjee S; Fiala M; Arroyave C; Azen S; Cosgrove D
J Med Virol; 1982; 9(3):237-44. PubMed ID: 6284872
[TBL] [Abstract][Full Text] [Related]
28. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
29. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
30. [Berger's disease. Study of eleven cases (author's transl)].
García García L; Giménez Llort A; Camacho Díaz JA; Cusí Sánchez MV; López Cacho F
An Esp Pediatr; 1982 Mar; 16(3):210-8. PubMed ID: 6980613
[TBL] [Abstract][Full Text] [Related]
31. In vitro complement activation by intercellular antibodies.
Hashimoto T; Sugiura M; Kurihara S; Nishikawa T
J Invest Dermatol; 1982 Apr; 78(4):316-8. PubMed ID: 6978365
[TBL] [Abstract][Full Text] [Related]
32. [Hereditary angioedema: description of a sibship and review].
Matter L; Schopfer K; Voegelin HP; Fueter R
Schweiz Med Wochenschr; 1981 Aug; 111(34):1238-45. PubMed ID: 6974398
[TBL] [Abstract][Full Text] [Related]
33. Complement aberrations in serum from children with otitis due to S. pneumoniae or H. influenzae.
Prellner K; Nilsson NI
Acta Otolaryngol; 1982; 94(3-4):275-82. PubMed ID: 6983204
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
35. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
Tönnessen TI; Nyland H; Aarli JA
Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
[TBL] [Abstract][Full Text] [Related]
36. The value of complement measurements in the assessment of lupus activity.
Milis L; Timmermans V; Morris CA; Pussell BA; Charlesworth JA
Aust N Z J Med; 1992 Aug; 22(4):338-44. PubMed ID: 1445021
[TBL] [Abstract][Full Text] [Related]
37. Semiologic value of C1q and C4 cutaneous deposits. An immunofluorescent study.
Gomes MA; Fernandez-Bussy R; Ohrt C; Thivolet J
J Cutan Pathol; 1982 Jun; 9(3):169-74. PubMed ID: 6752226
[TBL] [Abstract][Full Text] [Related]
38. Complement function and the synthesis of lung surfactant may be a regulation which preterm infants have in common.
Miyano A; Kitajima H; Fujiwara F; Nakayama M; Fujita T; Fujimura M; Takeuchi T; Shimizu A
Complement Inflamm; 1991; 8(5-6):320-7. PubMed ID: 1802550
[TBL] [Abstract][Full Text] [Related]
39. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
40. [Development of the serum levels of complement during the first year of life].
Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
